AU555504B2 – Treatment of myotonic conditions with tetrahydroisoxazolo (5,4-c) pyridin-3-ol
– Google Patents
AU555504B2 – Treatment of myotonic conditions with tetrahydroisoxazolo (5,4-c) pyridin-3-ol
– Google Patents
Treatment of myotonic conditions with tetrahydroisoxazolo (5,4-c) pyridin-3-ol
Info
Publication number
AU555504B2
AU555504B2
AU74781/81A
AU7478181A
AU555504B2
AU 555504 B2
AU555504 B2
AU 555504B2
AU 74781/81 A
AU74781/81 A
AU 74781/81A
AU 7478181 A
AU7478181 A
AU 7478181A
AU 555504 B2
AU555504 B2
AU 555504B2
Authority
AU
Australia
Prior art keywords
tetrahydroisoxazolo
pyridin
treatment
myotonic
conditions
Prior art date
1980-09-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn – After Issue
Application number
AU74781/81A
Other versions
AU7478181A
(en
Inventor
Ronald Charles Hill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1980-09-01
Filing date
1981-08-31
Publication date
1986-09-25
1981-08-31
Application filed by Sandoz AG
filed
Critical
Sandoz AG
1982-03-11
Publication of AU7478181A
publication
Critical
patent/AU7478181A/en
1986-09-25
Application granted
granted
Critical
1986-09-25
Publication of AU555504B2
publication
Critical
patent/AU555504B2/en
2001-08-31
Anticipated expiration
legal-status
Critical
Status
Withdrawn – After Issue
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P21/00—Drugs for disorders of the muscular or neuromuscular system
A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
AU74781/81A
1980-09-01
1981-08-31
Treatment of myotonic conditions with tetrahydroisoxazolo (5,4-c) pyridin-3-ol
Withdrawn – After Issue
AU555504B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
GB8028199
1980-09-01
GB8028199
1980-09-01
Publications (2)
Publication Number
Publication Date
AU7478181A
AU7478181A
(en)
1982-03-11
AU555504B2
true
AU555504B2
(en)
1986-09-25
Family
ID=10515772
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU74781/81A
Withdrawn – After Issue
AU555504B2
(en)
1980-09-01
1981-08-31
Treatment of myotonic conditions with tetrahydroisoxazolo (5,4-c) pyridin-3-ol
Country Status (6)
Country
Link
US
(1)
US4362731A
(en)
JP
(1)
JPS5777618A
(en)
AU
(1)
AU555504B2
(en)
BE
(1)
BE890136A
(en)
IT
(1)
IT1138543B
(en)
PH
(1)
PH17018A
(en)
Families Citing this family (36)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
GB8813185D0
(en)
*
1988-06-03
1988-07-06
Wyeth John & Brother Ltd
New method & amines used therein
ES2251651T3
(en)
*
1993-12-28
2008-07-16
Allergan, Inc.
USE OF THE BOTULINIC TOXIN NEUROTOXIC COMPONENT TO TREAT MUSCULAR SPASMS.
DE19525598C2
(en)
*
1995-07-13
1997-09-25
Max Planck Gesellschaft
sleeping pills
US6284794B1
(en)
*
1996-11-05
2001-09-04
Head Explorer Aps
Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
US6544555B2
(en)
2000-02-24
2003-04-08
Advancis Pharmaceutical Corp.
Antibiotic product, use and formulation thereof
US6565882B2
(en)
2000-02-24
2003-05-20
Advancis Pharmaceutical Corp
Antibiotic composition with inhibitor
US20020068078A1
(en)
2000-10-13
2002-06-06
Rudnic Edward M.
Antifungal product, use and formulation thereof
US6541014B2
(en)
2000-10-13
2003-04-01
Advancis Pharmaceutical Corp.
Antiviral product, use and formulation thereof
AR031473A1
(en)
*
2000-11-20
2003-09-24
Lundbeck & Co As H
GABA INTENSIFIERS IN THE TREATMENT OF DISEASES RELATED TO A REDUCED NEUROSTEROID ACTIVITY
US20020119168A1
(en)
*
2001-02-20
2002-08-29
Rudnic Edward M.
Therapeutic agent delivery
US8425936B2
(en)
2003-07-21
2013-04-23
Shionogi Inc.
Antibiotic product, use and formulation thereof
AU2004258949B2
(en)
2003-07-21
2011-02-10
Shionogi, Inc.
Antibiotic product, use and formulation thereof
JP2006528190A
(en)
2003-07-21
2006-12-14
アドバンシス ファーマスーティカル コーポレイション
Antibiotic preparations, their use and preparation
AU2004264939A1
(en)
2003-08-11
2005-02-24
Middlebrook Pharmaceuticals, Inc.
Robust pellet
EP1653924A4
(en)
2003-08-12
2009-09-09
Middlebrook Pharmaceuticals In
Antibiotic product, use and formulation thereof
JP5686494B2
(en)
2003-08-29
2015-03-18
シオノギ インコーポレイテッド
Antibiotic preparations, their use and preparation
CA2538064C
(en)
2003-09-15
2013-12-17
Advancis Pharmaceutical Corporation
Antibiotic product, use and formulation thereof
US20050137222A1
(en)
*
2003-12-18
2005-06-23
H. Lundbeck A/S
Treatment of insomnia in human patients
GB0402118D0
(en)
2004-01-30
2004-03-03
Merck Sharp & Dohme
Polymorphic forms of a GABAA agonist
MXPA06015196A
(en)
*
2004-06-29
2007-03-15
Lundbeck & Co As H
Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis.
CA2572292A1
(en)
2004-07-02
2006-02-09
Advancis Pharmaceutical Corporation
Tablet for pulsed delivery
US8778924B2
(en)
2006-12-04
2014-07-15
Shionogi Inc.
Modified release amoxicillin products
US8357394B2
(en)
2005-12-08
2013-01-22
Shionogi Inc.
Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2
(en)
2006-05-05
2012-10-30
Shionogi Inc.
Pharmaceutical compositions and methods for improved bacterial eradication
PT3151832T
(en)
2014-06-06
2021-06-15
Ovid Therapeutics Inc
Methods of increasing tonic inhibition and treating secondary insomnia
US9682069B2
(en)
2015-07-17
2017-06-20
Ovid Therapeutics Inc
Methods of treating Dravet syndrome
EP3324961A4
(en)
2015-07-17
2019-03-13
Ovid Therapeutics, Inc.
Methods of treating developmental disorders with gaboxadol
US9399034B1
(en)
2015-08-11
2016-07-26
Ovid Therapeutics Inc
Methods of sedation during critical care treatment
CN109715151A
(en)
2016-08-11
2019-05-03
奥维德医疗公司
For treating the method and composition of epilepsy sexual disorder
US10071083B2
(en)
2017-02-03
2018-09-11
Ovid Therapeutics Inc
Use of gaboxadol in the treatment of tinnitus
US20180338959A1
(en)
2017-05-24
2018-11-29
Ovid Therapeutics Inc.
Treatment of depressive disorders
AU2018309049A1
(en)
2017-08-04
2020-02-27
Ovid Therapeutics Inc.
Use of gaboxadol in the treatment of diabetes and related conditions
US10765666B2
(en)
2018-09-20
2020-09-08
Ovid Therapeutics Inc
Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering
CN113395962A
(en)
2018-11-21
2021-09-14
Certego治疗公司
Gaboxadol for reducing suicidal risk and rapidly relieving depression
US11690829B2
(en)
2018-12-17
2023-07-04
Ovid Therapeutics Inc.
Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder
KR20230028244A
(en)
2020-05-20
2023-02-28
썰테고 테라퓨틱스 아이엔씨.
Cyclic deuterated gaboxadol and its use for the treatment of mental disorders
1981
1981-08-26
US
US06/296,327
patent/US4362731A/en
not_active
Expired – Fee Related
1981-08-28
BE
BE1/10302A
patent/BE890136A/en
not_active
IP Right Cessation
1981-08-31
IT
IT23700/81A
patent/IT1138543B/en
active
1981-08-31
JP
JP56136931A
patent/JPS5777618A/en
active
Pending
1981-08-31
AU
AU74781/81A
patent/AU555504B2/en
not_active
Withdrawn – After Issue
1981-09-01
PH
PH26130A
patent/PH17018A/en
unknown
Also Published As
Publication number
Publication date
US4362731A
(en)
1982-12-07
IT1138543B
(en)
1986-09-17
PH17018A
(en)
1984-05-11
JPS5777618A
(en)
1982-05-15
AU7478181A
(en)
1982-03-11
IT8123700D0
(en)
1981-08-31
BE890136A
(en)
1982-03-01
Similar Documents
Publication
Publication Date
Title
AU555504B2
(en)
1986-09-25
Treatment of myotonic conditions with tetrahydroisoxazolo (5,4-c) pyridin-3-ol
AU572724B2
(en)
1988-05-12
1,4 – diketo – pyrrolo (3,4-c) – pyrrols
AU521040B2
(en)
1982-03-11
Isoxazolo [5, 4-c] pyridine compounds
AU545876B2
(en)
1985-08-01
Furo-(3,4-c)-pyridine
AU537916B2
(en)
1984-07-19
Glass bushing
AU518814B2
(en)
1981-10-22
Glaucoma treatment
NZ190427A
(en)
1982-08-17
3h-pyrazolo (3,4-c)isoquinoline or thiazolo(5,4-c)isoquinoline derivatives
AU549628B2
(en)
1986-02-06
7-substituted 2,3-dihydrobenzofurans
AU568894B2
(en)
1988-01-14
4,5,6,7 – tetrahydrothiazolo (5,4-c) pyridine derivatives
AU537631B2
(en)
1984-07-05
Solution mining process
GB2031426B
(en)
1983-01-12
Imidazo(2',1':2,3)thiazolo(5,4-c)pyridines and related compounds
AU544360B2
(en)
1985-05-23
6-hydrazono-pyrido(2,1-b)quinazoline-11-ones
AU534271B2
(en)
1984-01-12
S-triazolo(3,4-c)benzo-as-triazine derivatives
AU7683381A
(en)
1982-05-06
Treatment of diabetes with biolin (vitamin-h)
DE3160035D1
(en)
1983-03-03
Process for the preparation of 1,4-diamino-2,3-dicyano-anthraquinone
JPS56161367A
(en)
1981-12-11
Manufacture of 3-mercapto-propanediol-(1,2)
GB2029408B
(en)
1982-07-28
4h-s-traizolo(3,4-c)theino(2,3-e)1,4-diazepines
AU543040B2
(en)
1985-03-28
Gas carburising
GB2016463A
(en)
1979-09-26
2-phenyl-5,6-dihydro-4-pyrone derivatives
SU632685A1
(en)
1978-11-15
Method of isolating 2,3-oxynaphthoic acid
AU528863B2
(en)
1983-05-19
Treatment of ulcers with bis-chromonyl compounds
AU535884B2
(en)
1984-04-12
4-aryl-5,6,7,8-tetrahydropyrazolo(3,4-b)-(1,5)diazepine-1h,4 -5,7-diones
AU520063B2
(en)
1982-01-14
Substituted 4h-s-triazolo(3,4-c)thieno(2,3-e)1,4-diazepines
JPS5732282A
(en)
1982-02-20
Manufacture of indolo(2',3';3,4)pyrido(2,1- b)quinazoline-5-one
AU537591B2
(en)
1984-07-05
Derivatives of 2-amino-6,7-dihydroxytetrahydro-naphthalene (adtn)
None